Physiologic and laboratory correlates of depression, anxiety, and poor sleep in liver cirrhosis by Fang-Yuan Ko et al.
Ko et al. BMC Gastroenterology 2013, 13:18
http://www.biomedcentral.com/1471-230X/13/18RESEARCH ARTICLE Open AccessPhysiologic and laboratory correlates of
depression, anxiety, and poor sleep in liver
cirrhosis
Fang-Yuan Ko1, Albert C Yang2,3,4, Shih-Jen Tsai2,3, Yang Zhou1 and Lie-Ming Xu1*Abstract
Background: Studies have shown psychological distress in patients with cirrhosis, yet no studies have evaluated
the laboratory and physiologic correlates of psychological symptoms in cirrhosis. This study therefore measured
both biochemistry data and heart rate variability (HRV) analyses, and aimed to identify the physiologic correlates of
depression, anxiety, and poor sleep in cirrhosis.
Methods: A total of 125 patients with cirrhosis and 55 healthy subjects were recruited. Each subject was assessed
through routine biochemistry, 5-minutes ECG monitoring, and psychological ratings of depression, anxiety, and
sleep. HRV analysis were used to evaluate autonomic functions. The relationship between depression, sleep, and
physiologic correlates was assessed using a multiple regression analysis and stepwise method, controlling for age,
duration of illness, and severity of cirrhosis.
Results: Reduced vagal-related HRV was found in patients with severe liver cirrhosis. Severity of cirrhosis measured
by the Child-Pugh score was not correlated with depression or anxiety, and only had a weak correlation with poor
sleep. The psychological distress in cirrhosis such as depression, anxiety, and insomnia were correlated specifically
to increased levels of aspartate aminotransferase (AST), increased ratios of low frequency to high frequency power,
or reduced nonlinear properties of HRV (α1 exponent of detrended fluctuation analysis).
Conclusions: Increased serum AST and abnormal autonomic nervous activities by HRV analysis were associated
with psychological distress in cirrhosis. Because AST is an important mediator of inflammatory process, further
research is needed to delineate the role of inflammation in the cirrhosis comorbid with depression.
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Cirrhosis is a consequence of chronic liver disease com-
monly caused by alcoholism, viral hepatitis, autoimmune
disorders, or other aetiologies. The prevalence of liver
cirrhosis is high in most Asian countries where chronic
hepatitis B or C are common [1]. Cirrhosis places a sig-
nificant burden of psychological stress on affected indivi-
duals [2,3]. In patients with liver cirrhosis, quality of life
is considerably impaired and associated with mild to
moderate depression and anxiety [4-6]. In a study of one
hundred and fifty-six Italian patients with liver cirrhosis,* Correspondence: xulieming@126.com
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reproduction in any medium, provided the orBianchi et al. [6] demonstrated that the global score of
Psychological General Well-Being Index was severely
reduced compared to the population norm and the score
was significantly correlated with the severity of liver fail-
ure as assessed by the Child–Pugh (CP) score.
Despite the relationship between cirrhosis and dis-
tressed psychological states being well-documented in
aforementioned studies, no study has evaluated the la-
boratory and physiologic correlates of depression, an-
xiety, or poor sleep commonly seen in patients with
cirrhosis. Furthermore, these psychological manifesta-
tions are known risk factors for cardiovascular morbidity
and are also associated with autonomic dysregulation. A
body of research has emerged demonstrating that
reduced vagal modulation or increased sympatheticThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[10], and insomnia [11-13]; hence, the physiological and
psychological stress of cirrhosis may be measured by
heart rate variability (HRV), a non-invasive measure of
the cardiac autonomic nervous system.
Functional limitations, altered cardiac autonomic ac-
tivity, and psychological distress are known disorders in
patients with liver cirrhosis, relating to increased mor-
bidity and mortality. However, the inter-relationship be-
tween these morbidity remains unclear. The aim of this
study was therefore to examine the influence of seve-
rity of cirrhosis on emotional parameters and heart
rate variability (HRV) indices, as well as to determine
whether emotional distress contributes to autonomic
dysfunction in these patients. To this end, this study
measured both the biochemical data and HRV indices,
and identified the physiologic and laboratory correlates
of depression, anxiety, and poor sleep in patients with
liver cirrhosis.Methods
Patients
The study sample consisted of 125 patients with liver cir-
rhosis (73 males, 52 females; mean age = 58.3 ± 11.6 years)
and 55 healthy controls (29 males, 26 females; mean age =
58.0 ± 11.8 years) recruited from the outpatient clinics of
the Section of Liver Cirrhosis, Shuguang Hospital, China.
Inclusion criteria were a positive diagnosis of liver cirrho-
sis, documented by histology through a liver biopsy, or
through clinical, sonographic and endoscopic evidence of
portal hypertension and confirmed with laboratory data.
Exclusion criteria were (1) a history of major mental ill-
ness such as schizophrenia, major depression, or bipolar
disorder; (2) current use of psychotropic medication; (3)
active infections; (4) hepatocellular carcinoma evidenced
by sonographic focal liver lesion or α-fetoprotein exceed-
ing ten times the upper limits of normal values. Of note:
patients with viral hepatitis were neither actively treated
with interferon at the time of investigation or during the
previous year. The control subjects had neither history of
mental illness nor liver diseases.
Demographic and clinical variables included age, gender,
duration of illness, history of viral hepatitis and alcohol
dependence, routine biochemistry, and the five items of
the CP score (albumin and total bilirubin levels, pro-
thrombin activity, presence and severity of ascites and en-
cephalopathy) [14]. Of 125 patients, 43 were classified as
CP class A, 58 were class B, and 24 were class C. The
study protocol was in accordance with the guidelines for
clinical research and was approved by the Institutional
Review Board and the Ethical Review Committee of the
hospital. Informed consent was obtained after all subjects
had been fully informed of its purpose.Psychological measurements
Depression severity was evaluated with the Hamilton
Depression Rating Scale (HAMD, 24 items) [15], and
anxiety was evaluated with the Hamilton Anxiety Scale
(HAMA) [16]. Subjective sleep quality was assessed
through the Pittsburgh Sleep Quality Index (PSQI). The
ratings were administered by experienced clinical raters
certified with high rates of inter-rater reliability and
levels of procedural integrity. The self-reported depres-
sion scale, such as Beck Depression Inventory (BDI), [17]
was not used in this study because the Chinese version
of BDI was found to have low reliability in the Chinese
population due to cultural bias on depression [18]. The
objective rating of depression by HAMD and HAMA
may be more appropriate than self-reported measure in
our study population.
ECG monitoring
A customized ECG recording device was used to obtain
a 5-minute ECG from each recruited subject [19]. ECG
signals were recorded at a sampling rate of 256 Hz, and
were automatically processed and analyzed by open
source HRV algorithms [20]. All ECG monitoring took
place during the daytime, and participants were asked to
avoid smoking and to remain in a resting state while
being monitored.
Analysis of heart rate variability
The standard HRV analysis has been well reviewed [21].
Time domain measures of HRV include the mean heart
rate and standard deviation of the normal interbeat
intervals (SDNN), and the root mean square successive
difference between adjacent normal interbeat intervals
(RMSSD). The SDNN assesses the overall variability of
interbeat intervals. The RMSSD measures the short-term
variation of interbeat intervals, which is primarily modu-
lated by parasympathetic innervation [22]. Standard spec-
tral HRV measures [21] include high-frequency power (HF;
0.15–0.40 Hz), low-frequency power (LF; 0.04–0.15 Hz),
and very low-frequency power (VLF; 0.003–0.04 Hz). LF
power is suggested to be modulated by both sympathetic
and parasympathetic activities, whereas HF power is
mainly modulated by parasympathetic activity [23,24]. The
LF/HF ratio is considered a measure of the shift of sym-
pathovagal balance toward sympathetic activity [21,25].
The physiological mechanism underlying VLF power is
disputed but has been suggested to be mediated partly by
the renin–angiotensin–aldosterone system or by parasym-
pathetic modulation [26].
In addition, we incorporated a nonlinear HRV index:
a Detrended Fluctuation Analysis (DFA) [27,28]. DFA
quantifies the presence of long-range (fractal) correla-
tions inherent in physiologic signals and is therefore a
complexity measure. The details of the DFA method is
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resource for complex physiologic signals [20]. The root-
mean-square fluctuation of integrated and detrended
time series was measured at different observation win-





A (N = 43)
Demographic
Age, year 58.0 ± 11.8 56.6 ± 12.0
Gender, Male (%) 29 (52.7) 25 (58.1)
Clinical
Child-Pugh score 5.6 ± 0.5
Duration of illness, year 3.2 ± 3.4
Viral hepatitis, N (%) 32 (74.4)
Alcoholism, N (%) 1 (2.3)
Parasite, N (%) 2 (4.7)
Autoimmune, N (%) 2 (4.7)
Hepatic-encephalopathy, N (%) 0 (0)
Ascites, N (%) 3 (7.0)
Albumin, g/L 35.4 ± 4.5
ALT, U/L 46.7 ± 44.7
AST, U/L 40.2 ± 21.7
GGT, U/L 71.2 ± 87.0
ALP, U/L 102.4 ± 60.6
T-Bil, μmol/L 23.2 ± 7.4
D-Bil, μmol/L 6.4 ± 3.2
INR 1.24 ± 0.14
Psychological measurements
PSQI 6.4 ± 3.2
HAMD 10.0 ± 10.4
HAMA 5.8 ± 4.9
Heart rate variability
Mean heart rate, beats/minute 84.4 ± 11.8 75.4 ± 11.0
SDNN, ms 42.9 ± 15.1 34.7 ± 15.3
RMSSD, ms 28.2 ± 10.1 29.7 ± 14.8
VLF power, ln(ms2/Hz) 7.58 ± 0.84 6.95 ± 0.96
LF power, ln(ms2/Hz) 6.99 ± 0.84 6.33 ± 1.12
HF power, ln(ms2/Hz) 6.56 ± 0.88 6.22 ± 1.17
LF/HF ratio 1.67 ± 0.65 1.39 ± 0.98
DFA, α 0.80 ± 0.10 0.77 ± 0.15
DFA, α1 1.14 ± 0.18 0.91 ± 0.27
DFA, α2 0.94 ± 0.15 0.94 ± 0.22
Post-hoc: (H) healthy control; (A) Child-Pugh Class A; (B) Child-Pugh Class B; (C) Chil
aminotransferase; GGT: Gamma-Glutamyltransferase; ALP: Alkaline phosphatase; T-B
blood coagulation; PSQI: Pittsburgh sleep quality index; HAMD: Hamilton rating sca
fluctuation analysis.window on a log-log scale. The scaling exponent α is
then derived from the slope of line fitting to the gene-
rated log-log plot. The short-term exponent α1 (4 to 11
heartbeats) and the long-term scaling exponents α2 (>11
heartbeats) were also calculated [27,29]. Low-exponentariability characteristics
p Post-hoc
B (N = 58) C (N = 24)
58.6 ± 11.1 60.7 ± 12.1 0.578
36 (62.1) 12 (50.0) 0.680
7.9 ± 0.8 10.5 ± 0.9 <0.001 A < B < C
3.1 ± 4.0 3.5 ± 3.6 0.940
37 (63.8) 14 (58.3) 0.346
8 (13.8) 5 (20.8) 0.048 A < B < C
1 (1.7) 2 (8.3) 0.368
3 (5.2) 0 (0) 0.533
5 (8.6) 2 (8.4) 0.143
21 (36.2) 21 (87.5) <0.001 A < B < C
26.8 ± 4.9 26.2 ± 4.7 <0.001 A > B = C
39.3 ± 34.1 59.7 ± 77.7 0.233
57.5 ± 34.5 79.9 ± 54.2 <0.001 A = B < C
68.0 ± 69.4 95.8 ± 105.6 0.384
114.2 ± 56.7 135.0 ± 59.9 0.105
42.3 ± 38.8 91.9 ± 47.1 <0.001 A < B < C
14.1 ± 21.3 44.3 ± 33.9 <0.001 A = B < C
1.66 ± 1.68 1.69 ± 0.36 0.185
7.6 ± 4.6 10.0 ± 5.2 0.007 A = B < C
11.2 ± 10.2 17.4 ± 9.6 0.017 A = B < C
6.6 ± 5.9 8.8 ± 6.2 0.125
80.1 ± 14.0 83.8 ± 16.7 0.011 H > A
33.3 ± 20.5 22.8 ± 13.8 <0.001 H = A = B > C
27.8 ± 19.8 18.3 ± 11.7 0.035 H = A = B > C
6.60 ± 1.37 6.19 ± 1.22 0.051
5.84 ± 1.19 5.21 ± 1.48 <0.001 H = A > B > C
5.81 ± 1.26 4.91 ± 1.60 0.044 H = A = B > C
1.29 ± 0.87 1.76 ± 1.42 0.086
0.77 ± 0.17 0.83 ± 0.13 0.340
0.81 ± 0.31 0.89 ± 0.25 <0.001 H > A = B = C
0.98 ± 0.23 1.02 ± 0.20 0.384
d-Pugh Class C; ALT: Alanine aminotransferase; AST: Aspartate
il: Total bilirubin; D-Bil: Direct bilirubin; INR: International normalized ratio of
le for depression; HAMA: Hamilton rating scale for anxiety; DFA: Detrended
Table 2 Regression model of clinical and psychological





β SE Partial correlation P
PSQI
AST 0.025 0.011 0.224 0.027
HAMD
LF/HF ratio 2.777 1.247 0.222 0.028
AST 0.062 0.036 0.170 0.045
DFA, α1 −11.72 6.27 −0.186 0.041
HAMA
LF/HF ratio 1.351 0.713 0.190 0.039
DFA, α1 −4.683 2.506 −0.187 0.041
PSQI: Pittsburgh sleep quality index; HAM-D: Hamilton rating scale for
depression; HAM-A: Hamilton rating scale for anxiety.
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dynamics and have been implicated in increased risks of
fatal cardiac arrhythmia, increased mortality, or poor
prognosis in cardiovascular diseases [30-33].
Statistical analysis
Statistical Package for the Social Sciences (SPSS version
15.0, Chicago, IL) software was used for the statistical ana-
lyses. The spectral HRV indices were log transformed to
produce normalized distributions. Chi-squared tests were
used to compare categorical variables. One-way Analysis
Of Variance (ANOVA) was used to test for differences in
demographical, clinical, and HRV measures among groups
according to CP class, and post hoc Bonferroni tests were
used for paired-group comparisons. Partial correlation
controlling for age and duration of illness was used to test
the association between CP scores and psychological dis-
tress as well as HRV indices. The relationship between de-
pression, sleep, and physiologic correlates was assessed
with multiple regression analyses using the backward se-
lection method, controlling for age, duration of illness,
and CP score. The physiologic correlates included bio-
chemical data and HRV indices. We estimated the total
sample size by the power analysis to be at least 118 by as-
suming power of 80%, 5% significance level, and a total of
10 predictors. The Variance Inflation Factor (VIF) was
estimated for all physiologic correlates and a VIF value of
10 or greater was considered an indication of significant
co-linearity. A p value of less than 0.05 (two-tailed) was
required for all statistical comparisons.
Results
Patients
Table 1 shows the profiles of demographic, clinical and
psychological ratings, as well as HRV data according to
CP class. Three groups did not differ in age, gender and
duration of illness. Regarding the aetiologies of liver cir-
rhosis, patients with CP class B and C had higher rate of
alcoholism, compared to those with CP class A. The
ANOVA test showed significant between-group differ-
ences in serum levels of albumin (p < 0.001), aspar-
tate aminotransferase (AST; p < 0.001), total bilirubin
(p < 0.001), and direct bilirubin (p < 0.001). As expected,
post-hoc tests revealed that assessments of biochemis-
try were in accordance with the CP class.
Psychological ratings
Regarding psychological ratings (Table 1), signifi-
cant between-group differences were found in PSQI
(p = 0.007), and HAMD (p = 0.017). Patients with CP
class C had significantly higher PSQI and HAMD rat-
ings than patients with CP class A or B, suggesting
poorer sleep and more severe depressed moods in
cases of advanced liver cirrhosis.HRV analysis
For HRV measures (Table 1), significant between-group
differences were found in mean heart rate (p = 0.011),
SDNN (p < 0.001), RMSSD (p = 0.035), LF power (p <
0.001), HF power (p = 0.044), and DFA α1 (p < 0.001).
Patients with CP class C had a significantly decreased
SDNN and LF, and decreased vagal-related HRV such as
RMSSD and HF power, compared to controls and those
with CP class A or B.Correlation between CP score and psychological ratings /
HRV analysis
Partial correlation analysis controlling for age and du-
ration of illness indicated that CP scores were signifi-
cantly correlated to levels of PSQI (r = 0.210; p = 0.021),
and sub-components of PSQI, including subjective sleep
quality (r = 0.217; p = 0.017) and sleep efficiency (r =
0.202; p = 0.027). CP scores were not correlated to
HAMD and HAMA ratings. Regarding HRV indices, CP
scores were correlated negatively to RMSSD (r = −0.231;
p = 0.020), HF power (r = −0.345; p < 0.001), and posi-
tively to mean heart rate (r = 0.277; p = 0.005).Correlation between physiologic measures and
psychological ratings
Table 2 shows the physiologic correlates of depression,
anxiety and sleep using multiple regression models with
the stepwise method. PSQI was predicted only by AST
serum levels (r = 0.224; p = 0.027). HAMD was predicted
by LF/HF ratios (r = 0.222; p = 0.028), AST (r = 0.170;
p = 0.045), and DFA α1 (r = −0.186; p = 0.041). HAMA
was predicted by LF/HF ratios (r = 0.190; p = 0.039) and
DFA α1 (r = −0.187; p = 0.041).
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The key findings of this study were: (1) reduced vagal-
related HRV was found in patients with CP class C; (2)
severity of cirrhosis as measured by CP scores was not
correlated to depression or anxiety, and was only weakly
correlated with poor sleep; (3) the psychological distress in
cirrhosis such as depression, anxiety, and insomnia were
correlated specifically to increased levels of AST, increased
LF/HF ratios, or reduced nonlinear properties of HRV –
DFA α1. These results complemented prior research and
identified the physiologic factors associated with the seve-
rity of psychological distress in patients with cirrhosis.
Findings of compromised psychological status related
to the severity of cirrhosis were partially consistent with
prior studies [4-6,34,35]. Although patients with CP class
C showed significant psychological distress in sleep
(PSQI) and depression (HAMD), we only found a weak
correlation between CP scores and PSQI and its sub-
component. HAMD and HAMA scores, indicative of
depressed moods and anxiety, are not correlated with
cirrhosis severity (CP score) in our study. The aetiology
of depression in patients with liver cirrhosis remains
largely unknown [36]. This finding did not support the
study by Bianchi et al. that found a correlation between
CP scores and Beck Depression ratings [6]. By contrast,
we found that both PSQI and HAMD scores were corre-
lated with levels of AST, a more direct measure of liver
damage. This finding may provide a preliminary evi-
dence of the link between liver damage and psycho-
logical distress and suggests that individual biochemical
data may be more sensitive than CP scores in reflecting
the psychological burden of liver cirrhosis.
The cause of differential association between AST/ALT
markers and psychological ratings remains unknown. One
possible explanation is that AST/ALT ratio are commonly
elevated in cirrhosis patients and is a dependent marker of
fibrosis stage and cirrhosis [37]. In this study, there were
about 86% of patients who had AST/ALT ratio > 1 (data
not shown). The elevation of AST may be a more sensitive
marker to be correlated with psychological ratings. There
are limited data regarding the association between the ab-
normal liver function and psychological distress in liver
diseases. One prior study based on hepatitis C virus
infected patients found that the physical function subscale
in the quality of life assessment was correlated to serum
AST level [38]. AST is an important mediator of the
inflammatory processes, and increasing evidence has
suggested that pathophysiology of depression is closely
related to the proinflammatory cytokines [39], thus our
findings of the association between AST and poor sleep
and depression may be related to the chronic inflamma-
tion in cirrhosis, and warrants future investigation of
the association between the degree of liver inflammation
(e.g., necroinflammatory scores) and psychological ratings.Previous studies have found that reduced HRV was cor-
related with increased severity of cirrhosis [40-43]. This
study further reveals that both the severity of cirrhosis and
psychological distress are correlated with changes in HRV
indices. Although the causal relationship between these
factors remains unclear, CP scores only had a weak correl-
ation with poor sleep and no correlation with depression
and anxiety ratings, thus suggesting that the effects of
cirrhosis and psychological distress on HRV may be inde-
pendent. Studies on myocardial infarctions have sugge-
sted that depression is an independent risk factor for
poor cardiovascular outcomes [44-46]. Because cirrhosis
has frequent cardiovascular complications [47], cirrhosis
comorbid with depression may worsen cardiovascular-
related morbidity and mortality and warrants future
research. Of note, HAMD and HAMA scores were corre-
lated positively with LF/HF ratios – a marker of sym-
pathovagal balance – and negatively with DFA α1 – a
nonlinear marker of vagal activity [29,48]. DFA α1 has
repeatedly demonstrated its ability in predicting cardiovas-
cular mortality [48,49], and may be instrumental in further
investigations of using nonlinear HRV as a predictor of
cardiovascular complications in cirrhosis.
There are several limitations in our present study.
First, as the study design is cross-sectional, we cannot
directly evaluate the long-term impacts of cirrhosis and
psychological distress on autonomic function, and the
interpretation of results is exploratory. Second, our study
did not include a healthy control group; our primary
interest was to investigate physiologic correlates of psy-
chological distress within the population of cirrhosis
patients. Third, the psychiatric ratings were used as a
measure of psychological distress and were not for diag-
nostic purposes. The incidences of depression, anxiety,
and poor sleep in cirrhosis patients might be addressed
through psychiatric evaluation in a larger sample.
Conclusions
In summary, this study identifies the physiologic factors
associated with psychological distress in cirrhosis
patients, including increased AST and abnormal
autonomic-nervous activities determined through HRV
analyses. Further research is needed to evaluate the use
of HRV as a non-invasive tool to assess cardiovascular
outcome, and to delineate the role of inflammation in
the cirrhosis comorbid with depression.
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